# Safyral

NDC: 50419-403
Generic name: Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium
Labeler / Manufacturer: Bayer HealthCare Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: KIT
Routes: —
Marketing started: 20120213

FDA application: NDA022574

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50419-403"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50419-403
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=97563516-306a-4e17-9690-edbda49ecd83